15.29  0.383 (2.57%)		04-23 15:06
Open: 15 High: 15.29 Volume: 2,382		Pre. Close: 14.9074 Low: 15 Market Cap: 2,740(M)

Short term
Mid term
Targets	6-month :	18.44	1-year :	19.24
Resists	First :	15.79	Second :	16.47
Pivot price	15.53
Supports	First :	14.68	Second :	12.22
MAs	MA(5) :	15.02	MA(20) :	15.71
	MA(100) :	15.12	MA(250) :	13.77
MACD	MACD :	-0.3	Signal :	-0.2
%K %D	K(14,3) :	19.6	D(3) :	9.2
RSI	RSI(14): 42.7
52-week	High :	16.47	Low :	11.39

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ INNO ] has closed above bottom band by 35.9%. Bollinger Bands are 75.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	15.32 - 15.39	15.39 - 15.46
Low:	14.82 - 14.9	14.9 - 14.98
Close:	15.15 - 15.29	15.29 - 15.42

Under normal market conditions, the fund invests primarily in equity securities, principally common stocks, of companies selected based on their potential for growth tied to disruptive innovation. The adviser defines “disruptive innovation” as the development of new products, services, technologies and/or other advancements that could disrupt and displace existing businesses and business models over time. While the fund invests primarily in securities of U.S. companies, it may invest up to 25% of its assets in foreign securities, including those located in emerging market countries.

Tue, 23 Apr 2024
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain - Harbor ETF Trust - Benzinga

Mon, 22 Apr 2024
(INNO) Investment Analysis - News Stock Traders Daily

Tue, 13 Feb 2024
CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval - Har - Benzinga

Tue, 08 Aug 2023
Use INNO for Stability in Disruptive Innovation - ETF Trends

Fri, 10 Feb 2023
3 Harbor ETFs Returns Worth Noting in January 2023 - ETF Trends

Mon, 28 Feb 2022
This new competitor to the ARK Innovation ETF focuses on disruptive companies but aims to reduce volatility - MarketWatch

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.